Executives
-
Brunk Troy DPresident, Collins Aerospace -
Jasper Philip JPresident, Raytheon
-
Hayes GregoryExecutive Chairman
-
Mitchill Neil G. JrEVP, Chief Financial Officer
-
Johnson Amy LCorporate VP and Controller
-
Calio Christopher T.President and CEO
-
Williams Dantaya MEVP & Chief HR Officer
-
Maharajh RamsaranEVP and General Counsel
-
Eddy Shane GPresident, P&W
-
Dasilva Kevin GCorporate VP and Treasurer
-
Timm Stephen J.President, Collins Aerospace
?
Calio Christopher T.
President and CEO
Raytheon Technologies Corporation
US, Waltham [HQ]
CIK
1781357
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
927,440,000
Price per Share :
$120.46
Equivalence :
$111,719,422,400.00
Transaction History
-
M927,440,000 Shares After TransactionValue : $65,857,514,400.00$7,978,683,600.00Transaction Date : 07/29/24
-
Footnotes
-
-
Footnotes:#1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
-
S885,090,000 Shares After TransactionValue : $100,900,260,000.00Sold $4,827,900,000.00Transaction Date : 07/29/24
-
Footnotes
-
-
Footnotes:#1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
-
D815,080,000 Shares After TransactionValue : $92,878,366,000.00$7,977,639,500.00Transaction Date : 07/29/24
-
Footnotes
-
-
Footnotes:#1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
-
M570,740,000 Shares After TransactionValue : $48,781,147,800.00$4,074,354,900.00Transaction Date : 02/07/24
-
Footnotes
-
-
Footnotes:#1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
-
S567,070,000 Shares After TransactionValue : $52,527,694,100.00Sold $339,952,100.00Transaction Date : 02/07/24
-
Footnotes
-
-
Footnotes:#1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.